Skip to main content
Screener/Healthcare/Biotechnology

RAPP — Rapport Therapeutics, Inc. Common Stock

NASDAQ
$24.42+0.75 (+3.16%)
Small CapUnder $50Healthcare
$22.06
$52.93
$22.95
$24.53
EPS (TTM)$-2.60
P/E Ratio-14.22
Dividend Yield—
Market Cap$1.21B
Volume587K
Prev Close$23.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$20.0M-$19.9M$-0.420.0%-99.3%
Q4 '25$0-$33.8M$-0.72——
Q3 '25$0-$26.9M$-0.71——
Q2 '25$0-$26.7M$-0.75——
Q1 '25$0-$24.1M$-0.68——
Q4 '24$0-$20.0M$-0.57——
Q3 '24$0-$17.5M$-0.50——
Q2 '24$0-$18.1M$-0.50——
Get Your Daily Market Recap